期刊文献+

胃肠道侵袭性B细胞淋巴瘤临床病理学研究 被引量:5

Aggressive B-ceU lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases
原文传递
导出
摘要 目的探讨胃肠道侵袭性B细胞淋巴瘤即弥漫性大B细胞淋巴瘤(DLBCL)、Burkitt淋巴瘤(BL)、特征介于DLBCL和BL之间不能分类型的淋巴瘤(DLBCL/BL)的组织学特点,及其临床病理参数、免疫组织分型与预后的相关性。重点讨论c-myc抗体在胃肠道侵袭性B细胞淋巴瘤中的表达特点,及预测其基因易位的价值和意义。方法对54例胃肠道侵袭性B细胞淋巴瘤的临床资料、组织学、免疫组织化学(EnVision法)进行观察分析并随访;荧光原位杂交(FISH)检测所有病例c—myc和部分病例的bcl-2的基因状态;免疫组织化学检测c.mye、Tel-1及CD383种c-myc基因预测抗体的表达;统计分析各临床病理参数问及其与预后的关系,并对基因易位预测指标c-myc进行准确性检验(ROC曲线)。结果54例胃肠道侵袭性B细胞淋巴瘤,包括49例DLBCL(免疫分型:生发中心B细胞型1I例,活化B细胞型38例)、4例DLBCL/BL、1例BL,中位年龄56岁,男女之比为1.6:1.0,中位生存时间42个月,其中11例在97个月内死亡。组织学观察可见异型的大细胞弥漫浸润胃肠道壁全层,部分伴有核碎裂及星空现象(18/54)。瘤细胞CD20、CD79a均阳性,CIN3(4/54)、CD5(7/54)、bcl-2(26/54)、Tel-1(17/54)、CD38(15/54)部分阳性,CD3、CD30均阴性,Ki-67阳性指数40%一100%。FISH检测显示部分病例出现bcl一2(1/19)和c—myc(4/54)易位,后者免疫组织化学c—myc均阳性(阳性百分数为80%~100%)。单因素分析显示B症状、行为状态、乳酸脱氢酶、国际预后指数、远处转移、临床分期、c—myc阳性百分数90%以上、c-myc易位在内的8个因素与预后相关,CD5阳性的DLBCL预后不良,其中乳酸脱氢酶、远处转移、c—myc易位是独立的预后因素。ROC曲线显示c—mye抗体阳性百分数预测c-myc基因易位的最佳阈值为75%。结论胃肠� Objective To study the histological features, diagnosis, differential diagnoses of aggressive B-cell lymphomas of the gastrointestinal tract and to correlate clinical prognosis with pathologic parameters and immunophenotypes with an emphasis on c-myc, Tcl-1 and CD38 expression and their values in predicting the status of c-myc gene translocation. Methods Fifty-four cases of aggressive B-cell lymphomas of the gastrointestinal tract with complete clinical and pathologic data were retrospectively collected. The clinical data, histologic and immunohistochemical findings and follow-up results were analyzed. Predictive immunohistochemical stains including c-myc, Tcl-1 and CD38 were performed and ROC curve analysis was used to confirm the accuracy of these markers in predicting c-myc translocation. Results Of 54 cases, there were 33 males and 21 females with median age of 56 years. Histological types of lymphomas included 49 cases of DLBCL ( 11 cases of germinal central B cell like and 38 cases of activated B cell like by Hans classification), 4 cases of DLBCL/BL and 1 case of BL. Eleven of 54 patients died within
出处 《中华病理学杂志》 CAS CSCD 北大核心 2014年第1期8-14,共7页 Chinese Journal of Pathology
  • 相关文献

参考文献29

  • 1Gollub MJ. Imaging of gastrointestinal lymphoma[J]. Radiol Clin North Am, 2008, 46(2) :287-312. 被引量:1
  • 2Akyurek N, Uner A, Benekli M, et al. Prognostic significance of MYC, BCl2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab[J] . Cancer, 2012,118(17) :41734183. 被引量:1
  • 3Slack GW, Gascoyne RD. MYC and aggressive B-cell lymphomas[J]. Adv Anat Pathol, 2011, 18(3) :219-228. 被引量:1
  • 4Choi SY, Kim SJ, Kim WS, et al. Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis[J]. Virchows Arch, 2011 , 459 (5) :495-502. 被引量:1
  • 5ArmitageJO. Staging non-Hodgkin lymphoma[J]. CA CancerJ Clin, 2005, 55 (6) : 368-376. 被引量:1
  • 6Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J]. Blood, 2004, 103 ( 1 ) :275-282. 被引量:1
  • 7Rodig SJ, VergilioJA, Shahsafaei A, et al. Characteristic expression patterns of TCLl, CD38 , and CD44 identify aggressive lymphomas harboring a MYC translocation[J]' AmJ Surg Pathol, 2008, 32(1) : 113-122. 被引量:1
  • 8叶洪涛.间期荧光原位杂交技术及其临床病理应用[J].中华病理学杂志,2011,40(2):130-134. 被引量:7
  • 9Green TM, Nielsen 0, de Stricker K, et al. High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-celilymphoma[J]. AmJSurgPathol, 2012, 36(4) :612- 619. 被引量:1
  • 10Ventura RA,Martin-SuberoJI,Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue] J].J Mol Diagn, 2006, 8(2): 141-151. 被引量:1

二级参考文献19

  • 1王桂秋,周英琼,宫丽平,冯震博,董格红,高子芬,叶洪涛.用荧光原位杂交在石蜡切片上检测t(11;18)和涉及bcl-10基因染色体易位的方法[J].中华病理学杂志,2007,36(7):494-495. 被引量:27
  • 2Gozzetti A,Le Beau MM.Fluorescence in situ hybridization:uses and limitations.Semin Hematol,2000,37(4):320-333. 被引量:1
  • 3Martin-Subero JI,Gesk S,Harder L,et al.Interphase cytogenetics of haematological neoplasms under the perspective of the novel WHO classification.Anticancer Res,2003,23 (2A):1139-1148. 被引量:1
  • 4Waldman FM,Sauter G,Sudar D,et al.Molecular cytometry of cancer.Hum Pathol,1996,27(5):441-449. 被引量:1
  • 5Tibiletti MG,Bernasconi B,Dionigi A,et al.The applications of FISH in tumor pathology.Adv Clin Path,1999,3(4):111-118. 被引量:1
  • 6Belaud-Rotureau MA,Parrens M,Dubus P,et al.A comparative analysis of FISH,RT-PCR,PCR,and immunohistochemistry for the diagnosis of mantle cell lymphomas.Mod Pathol,2002,15(5):517-525. 被引量:1
  • 7Colleoni GW,Jhanwar SC,Ladanyi M,et al.Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCRABL to fluorescence in situ hybridization,Southern blotting,and conventional cytogenetics in the monitoring of patients with Ph1positive leukemias.Diagn Mol Pathol,2000,9(4):203-209. 被引量:1
  • 8Belaud-Roture au MA,Parrens M,Carrere N,et al.Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen Iymph node with follicular lymphoma.Hum Pathol,2007,38(2):365-372. 被引量:1
  • 9Kearney L.The Impact of the new fish technologies on the cytogenetics of haematological malignancies.Br J Haematol,1999,104(4):648-658. 被引量:1
  • 10Wolff AC,Hammond ME,Schwartz JN,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.J Clin Oncol,2007,25(1):118-145. 被引量:1

共引文献6

同被引文献20

  • 1Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of hematopoietic and lymphoid tissues [ M ]. Lyon : IARC Press, 2008. 被引量:1
  • 2Aukema SM, Siebert R, Schuuring E, et al. Double-hit B-cell lymphomas [ J]. Blood ,2011,117 ( 8 ) :2319-2331. 被引量:1
  • 3Snuderl M, Kolman OK, Chen YB, et al. B-cell Lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma [ J ]. Am J Surg Patho1,2010,34 ( 3 ) :327-340. 被引量:1
  • 4Pillai RK, Sathanoori M, Van Oss SB, et al. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B -cell lymphomas [ J ]. Am J Surg Pathol, 2013 37 ( 3 ) : 323-332. 被引量:1
  • 5Green TM, Young KH, Visco C, et al. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone [ J ]. J Clin Oncol,2012,30(28 ) :3460-3467. 被引量:1
  • 6Johnson NA, Slack GW, Savage K J, et al. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone [ J ]. J Clin Oncol,2012,30 (28) :3452-3459. 被引量:1
  • 7Horn H, Ziepert M, Becher C, et al. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma [ J ]. Blood,2013,121 ( 12 ) :2253-2263. 被引量:1
  • 8Thieblemont C, Briere J. MYC, BCL2, BCL6 in DLBCL:impact for clinics in the future? [ J]. Blood,2013,121 (12) : 2165-2166. 被引量:1
  • 9Pfreundschuh M. Growing importance of MYC/BCL2 immunohistochemistry in diffuse large B-cell lymphomas [ J ]. J Clin Oncol,2012,30(28) : 3433-3435. 被引量:1
  • 10Pedersen MO, Gang AO, Poulsen TS, et al. MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations [ J]. Eur J Haemato1,2014,92 ( 1 ) :42-48. 被引量:1

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部